GNH USA

Europe — EMA

Neo-Endusix (Tenoxicam)

GNH USA supplies Neo-Endusix (Tenoxicam), a nonsteroidal anti-inflammatory drug for pain relief and arthritis. Request a quote for global supply.

Request sourcing

1
Pack/s

What is Tenoxicam?

Tenoxicam, the active ingredient in Neo-Endusix, is an oxicam presented as an oral tablet for oral use. It is employed to relieve pain and reduce inflammation in conditions such as rheumatoid arthritis and osteoarthritis.\n\nGNH India supplies Neo-Endusix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Tenoxicam used for?

Tenoxicam is an NSAID that acts on inflammatory and musculoskeletal disorders.\n\nRheumatoid arthritis: reduces joint inflammation and pain.\nOsteoarthritis: alleviates chronic joint discomfort and swelling.\nAnkylosing spondylitis: improves spinal stiffness and pain.\nAcute pain: provides short‑term relief for postoperative or injury‑related pain.

What are the side effects of Tenoxicam?

Tenoxicam may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Gastrointestinal upset (nausea, dyspepsia)\n- Headache\n- Dizziness\n- Skin rash or pruritus\n- Mild elevation of liver enzymes\n- Edema\n\nSerious or Rare Side Effects:\n- Gastrointestinal ulceration or bleeding\n- Stevens‑Johnson syndrome or toxic epidermal necrolysis\n- Severe hepatic injury\n- Acute renal failure\n- Anaphylactic reactions\n- Hematologic abnormalities such as leukopenia

What precautions apply to Tenoxicam?

When prescribing Tenoxicam, clinicians should consider several safety measures.\n\nAssess gastrointestinal risk: evaluate history of ulcers or bleeding.\nMonitor renal function: especially in patients with existing kidney disease.\nUse caution in cardiovascular disease: NSAIDs may increase thrombotic risk.\nAvoid in known hypersensitivity to oxicams or other NSAIDs.\nPrescribe the lowest effective dose for the shortest duration needed.\nStore at room temperature: keep in the original container, protect from moisture and direct sunlight.

What does Tenoxicam interact with?

Tenoxicam can interact with various medicines, altering efficacy or safety.\n\nMajor Interactions (Avoid):\n- Anticoagulants (e.g., warfarin): increased bleeding risk.\n- Lithium: elevated lithium levels.\n- Methotrexate: enhanced toxicity.\n- Cyclosporine: heightened nephrotoxicity.\n- SSRIs or SNRIs: additive bleeding risk.\n\nModerate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: possible renal function decline.\n- Diuretics: risk of electrolyte imbalance.\n- Beta‑blockers: may mask tachycardia.\n- Digoxin: increased serum concentrations.\n- Concurrent NSAIDs: heightened gastrointestinal and renal adverse effects.

Frequently asked questions

What conditions is Neo-Endusix used to treat?+
Neo-Endusix contains Tenoxicam, an NSAID indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and short‑term relief of moderate to severe acute pain such as postoperative discomfort. It works by reducing inflammation and associated pain in these musculoskeletal disorders.
How does Tenoxicam work in the body?+
Tenoxicam blocks the activity of cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, the drug diminishes inflammation, pain, and fever at the site of tissue injury or disease.
What is the usual dose of Neo-Endusix?+
The appropriate dose of Neo-Endusix is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and response to therapy. Dosage adjustments may be required for special populations, and the prescriber will provide specific instructions.
Is Neo-Endusix safe to use during pregnancy or breastfeeding?+
The safety of Tenoxicam in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.
How do I order Neo-Endusix from GNH USA?+
To place an order, visit the product page on gnh-usa.com and submit an enquiry with the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Neo-Endusix compare with other NSAIDs?+
Tenoxicam belongs to the oxicam class, offering a longer half‑life than many traditional NSAIDs such as ibuprofen or diclofenac. This can allow once‑daily dosing for chronic conditions, but it also carries a similar risk profile for gastrointestinal, renal, and cardiovascular adverse effects. Choice of NSAID should be individualized based on efficacy, safety, and patient comorbidities.
What are the storage requirements for Neo-Endusix?+
Neo-Endusix should be stored at room temperature, below 25 °C (77 °F). Keep the tablets in the original packaging, protect them from moisture, excessive heat, and direct sunlight to maintain stability and potency throughout the shelf life.
How is Neo-Endusix administered?+
Neo-Endusix is taken orally, usually with a full glass of water. It may be taken with or without food, although taking it with meals can reduce gastrointestinal irritation. Patients should follow the dosing schedule prescribed by their healthcare professional.
What are the most serious risks associated with Neo-Endusix?+
Serious risks include gastrointestinal bleeding or ulceration, severe skin reactions such as Stevens‑Johnson syndrome, acute renal failure, and significant hepatic injury. Patients should be monitored for signs of these events, especially if they have pre‑existing risk factors or are using interacting medications.
Who should not use Neo-Endusix?+
Neo-Endusix is contraindicated in individuals with known hypersensitivity to Tenoxicam, other oxicams, or any NSAID. It should also be avoided in patients with active gastrointestinal ulceration, severe heart failure, or those who have experienced serious adverse reactions to similar drugs.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Tenoxicam
Route
Oral Use
Manufacturer
Anfarm Hellas Sa
Origin
EU

Related products